CHEPLAPHARM Arzneimittel GmbH
Search

IR Contact & Events

For us, dialogue, transparency and maintaining an individual exchange are fundamental values. We will gladly respond to your questions and concerns personally.

support_agent

Your contact persons

Stephanie Lemke

Senior Investor Relations Manager

Jens Remmers

Head of Treasury & Investor Relations

IR center of information

Financial Reports

28th April 2023
Publication Annual Report and ESG Report FY 2022
3rd May 2023
Earnings Call FY 2022 Results
26th May 2023
Publication Quarterly Report Q1 2023
01st June 2023
Earnings Call Quarterly Report Q1 2023
25th August 2023
Publication Half Year Report H1/6M 2023
31st August 2023
Earnings Call Half Year Report H1/6M 2023
27th November 2023
Publication Quarterly Report Q3/9M 2023
01st December 2023
Earnings Call Quarterly Report Q3/9M 2023
26th April 2024
Publication Annual Report and ESG Report FY 2023
30th April 2024
Earnings Call FY 2023 Results

If you would like to have access to our Investor Calls as well as our latest financial reports, please register in our Investors Domain.

Contact our Team

There are many ways to contact us: you can write us or give us a call, and you can also stay up-to-date by subscribing to our Newsletter.

Jens Remmers

Head of Treasury & Investor Relations

Stephanie Lemke

Senior Investor Relations Manager

Fabian Franke

Senior Investor Relations Manager

Always informed

Our IR-Newsletter





  I agree that the operator and publisher may inform me about selected topics. My data is used exclusively for this purpose. In particular, no disclosure to unauthorized third parties. I am aware that I can revoke my consent at any time with effect for the future. The Privacy Policy applies, which also includes other information about how to correct, delete and block my data.


*) required.

Investor Relations topics

Creditor Relations

chevron_right

Ratings

chevron_right

ESG Information

chevron_right

IR Contact & Events

chevron_right
Back to top expand_less